Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-05
1988-05-17
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142328, 5142348, 514267, 544116, 544250, 544283, A61K 3100, C07D41300
Patent
active
047451181
ABSTRACT:
Novel substituted quinazoline-3-oxides are disclosed as are methods of increasing cardiotonic activity and bronchodilation in which an unit dose of a composition containing an effective amount of a cardiotonic agent or a bronchodilating agent dispersed in a pharmaceutically acceptable carrier are administered to a mammalian host.
REFERENCES:
Brown, Heterocyclic Compounds, Fused Pyrimidines, Part 1, 1967, John Wiley & Sons, N.Y., pp. 450-452.
Fey, et al., "Chemical Abstracts", vol. 67(18), 1967, Col. 86253c.
T. Higashino, Chem. Pharm. Bull. Japan (1961) 9, 635.
Zenno, et al., Chemical Abstracts, vol. 70, (1969), Col. 28944c.
Zenno, et al., Chemical Abstracts, vol. 72, (1970), Col. 90506h.
Combs Donald W.
Falotico Robert
Hollrah Glennon H.
Lambert Benjamin F.
Ortho Pharmaceutical Corporation
Turnipseed James H.
LandOfFree
Substituted quinazoline-3-oxides providing pharmacological activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazoline-3-oxides providing pharmacological activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazoline-3-oxides providing pharmacological activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1881605